Analysis of the Global Human Albumin Market and Product Pipeline

Analysis of the Global Human Albumin Market and Product Pipeline

Emerging Economies and Use of Human Albumin as an Excipient Present New Growth Opportunities

RELEASE DATE
02-Sep-2015
REGION
Asia Pacific
Research Code: MB53-01-00-00-00
SKU: LS00110-AP-MR_16951
AvailableYesPDF Download
$4,950.00
In stock
SKU
LS00110-AP-MR_16951
$4,950.00
DownloadLink
ENQUIRE NOW

Description

The study covers provides an assessment of the marketed and pipeline products for the global human albumin market. Segmentation by application has been provided along with additional information such as clinical trial timelines and results, and historical and projected launch timelines. The marketed and pipeline products have been broadly segmented into those used in replacement therapy (fluid-volume replacement therapy), in drug formulation and delivery, as stabilisers for vaccines, and as excipients in imaging and in-vitro fertilisation products. The market shares of the key companies operating in this space have also been listed.

Table of Contents

Executive Summary—Key Findings

Executive Summary—Key Findings (continued)

Key Trends

Key Companies to Watch

Methodology and Scope

Market Overview—Introduction

Market Overview—Blood Plasma Production

Blood Plasma Market Share

Demand Analysis of Blood Plasma Proteins

Human Albumin Production

Market Forecast—Human Albumin

Market Forecast—Human Albumin Discussion

Supply Chain and Distribution Network

Supply Chain and Distribution Network (continued)

Porter’s 5 Forces Analysis

Porter’s 5 Forces Analysis (continued)

Porter’s 5 Forces Analysis (continued)

Human Albumin Market Share Analysis

Market Segmentation

Recommendations for Data Center Operators

Competitive Landscape—Marketed and Pipeline Products

Marketed Products—Replacement Therapy

Marketed Products—Replacement Therapy (continued)

Pipeline Products—Replacement Therapy

Marketed Products—Drug Formulation and Delivery

Marketed Products—Drug Formulation and Delivery (continued)

Pipeline Products—Drug Formulation and Delivery

Marketed Products—Vaccine

Pipeline Products—Vaccine

Marketed Products—Others

Total Human Albumin Market—Major Ongoing/Recently Completed Clinical Trials

Summary of Key Products to Watch

Timeline of Key Events—Launch of Products

Product Dashboard: Albuminar—CSL Behring

Product Dashboard: Albutein—Grifols

Product Dashboard: Abraxane—Celgene

Product Dashboard: Victoza—Novo Nordisk

Product Dashboard: Recombumin—Novozymes

Product Dashboard: rIX-FP—CSL Behring

Conclusions

Legal Disclaimer

The Frost & Sullivan Story

Value Proposition: Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy

Related Research
The infectious disease IVD market in Indonesian presents diversified growth potential for different tiers of participants. Domestic participants stand to gain from the growth momentum in the lower-end market, whereas foreign leading manufacturers dominate the higher-end market. This research service analyses the infectious disease IVD market and provides an in-depth analysis of revenue forecast by segment, drivers and restraints, and technology trends, along with the competitive factors and strategies. The infectious disease IVD market in Indonesia can be divided into segments such as microbiology testing, immunochemistry testing, and molecular diagnostics testing. The study covers the period 2012 to 2017.
More Information
No Index No
Podcast No
Author Sriram Radhakrishnan
WIP Number MB53-01-00-00-00
Keyword 1 Human albumin
Keyword 2 albumin
Is Prebook No